This study compared atopic dermatitis flares in patients who took topical corticosteroids (TCS) alone and patients who were on a combination treatment plan of TCS and dupilumab.
Read more at the Journal of the American Academy of Dermatology.
Preventing flares in adults with moderate-to-severe atopic dermatitis in a 52-week randomized controlled phase 3 trial
